Editorial Urology
Association between frailty screening and health-related quality of life: evidence from preterm neonates

Association between frailty screening and health-related quality of life: evidence from preterm neonates

Authors

Adam Kim

Adam Kim

Cleveland Clinic Abu Dhabi, South Africa

Corresponding
Malik Andersen

Malik Andersen

St Thomas' Hospital, American Samoa

Malik Costa

Malik Costa

Aga Khan University Hospital, Guinea

Published

June 11, 2025

Paper ID

PAP-000251

Status

Published

DOI

10.65712/tmj.test000509

Association between frailty screening and health-related quality of life: evidence from preterm neonates

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Practice around frailty screening varies widely between centres. Methods: Missing data were handled with multiple imputation. Results: Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.52 (95% CI 0.42 to 0.85). Conclusion: Residual confounding cannot be excluded.

References

1. Novak H, Silva F, et al. High-flow nasal oxygen and acute kidney injury. Ann Intern Med. 2014;370(3):436-1631.

2. Larsen V, Moreau X, et al. Tranexamic acid and surgical site infection. Crit Care Med. 2022;373(2):814-957.

3. Dubois R, Ibrahim F, et al. Delayed cord clamping and length of stay. Pediatrics. 2015;37(7):149-1786.

4. Kowalski Y, Silva F, et al. A sepsis alert system and falls. BMC Med. 2021;289(8):398-1177.

5. Okafor G, Haddad B, et al. An antibiotic stewardship programme and health-related quality of life. Diabetes Care. 2017;324(1):38-1623.

6. Ibrahim U, Osei R, et al. Frailty screening and medication adherence. Diabetes Care. 2025;388(5):781-1738.

7. Kowalski B, Nakamura B, et al. An antibiotic stewardship programme and in-hospital mortality. Pediatrics. 2014;227(12):95-1686.

8. Schmidt O, Osei K, et al. Pharmacist-led medication review and falls. Crit Care Med. 2013;385(6):127-1227.

9. Nasser A, Rahman Z, et al. An enhanced recovery pathway and time to diagnosis. Lancet. 2019;319(2):70-1206.

Introduction

Guidelines make only a weak recommendation on frailty screening. The cost of health-related quality of life to health systems is substantial.

Earlier studies of frailty screening were small or single-centre. health-related quality of life remains a leading cause of avoidable harm among preterm neonates.

The cost of health-related quality of life to health systems is substantial. health-related quality of life remains a leading cause of avoidable harm among preterm neonates.

Guidelines make only a weak recommendation on frailty screening. health-related quality of life remains a leading cause of avoidable harm among preterm neonates.

Materials and Methods

We conducted a randomised controlled trial across 7 centres between 2020 and 2024. Eligible participants were preterm neonates.

The primary outcome was health-related quality of life, assessed blind to allocation. Missing data were handled with multiple imputation.

We conducted a randomised controlled trial across 4 centres between 2015 and 2022. Missing data were handled with multiple imputation. We conducted a randomised controlled trial across 6 centres between 2015 and 2025.

Eligible participants were preterm neonates. The primary outcome was health-related quality of life, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.

Results

1202 participants were included (median age 61 years). The adjusted odds ratio was 0.91 (95% CI 0.35 to 0.76).

health-related quality of life occurred in 12% of the intervention group versus 16% of controls. Serious adverse events were rare and similar between groups.

GroupnEventsRate %OR95% CI
Centre A2239715.90.930.21–1.13
Centre B256169.60.920.39–1.28
Intervention5618412.30.800.59–1.19
Male4727124.10.880.24–1.12
Age ≥ 655571029.70.850.50–1.3
Intervention4926027.60.950.46–1.21
TABLE 1: Adverse events
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Trend in health-related quality of life
Shown for preterm neonates; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Trend in health-related quality of life
Shown for preterm neonates; error bars are 95% confidence intervals.

2895 participants were included (median age 55 years). The adjusted odds ratio was 0.64 (95% CI 0.26 to 0.62).

Discussion

Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.

Future work should test frailty screening in a pragmatic multicentre trial. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.

Implementation will depend on staffing, cost and local protocols. Future work should test frailty screening in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Conclusions

Frailty screening should be considered for preterm neonates to improve health-related quality of life.

Appendices

Supplementary tables are available on request.